The Latin America, Middle East and Africa Meningococcal Vaccine Market would witness market growth of 9.5% CAGR during the forecast period (2020-2026). The access to meningococcal vaccines is increasing in developing countries including Africa. This is mainly due to the increasing support of global organizations assisting vaccine procurement, prequalification, and funding is strengthening the lucrativeness of the market. Manufacturers are aiming at these under-penetrated markets to propel their growth in the meningococcal market.
Manufacturers are focused to incorporate advanced technologies in the manufacturing processes in order to develop new and more effective vaccines. For example, GlaxoSmithKline Plc. used new formulations, like a fully liquid production of a tetravalent vaccine for MenACWY and Menveo. Researchers nowadays are focused on the development of a single vaccine capable of tackling all five serogroups, A, B, C, W, and Y of meningococcus and it is the key area of focus for many vaccine manufacturing companies.
The meningococcal vaccine market is likely to experience substantial market growth in the coming years owing to surge in the adoption of immunization programs in several countries across the globe. In addition to it, the outbreak of meningococcal in several countries has resulted in increased demand for meningococcal vaccines, this, in turn, improves the growth of the market. However, in most of the countries, stringent regulations have been imposed for the approval of novel vaccines and it is expected to hinder the market growth. In contrast to this, increasing R&D for meningococcal vaccines and an increase in healthcare spending across the globe provide significant growth in lucrative opportunities for the market players of the meningococcal vaccine.
Based on Brand, the market is segmented into Bexsero, Trumenba, Nimenrix, Menactra, Menveo and Other Brands. Based on Type, the market is segmented into Bivalent, Quadrivalent and Other Types. Based on Age Group, the market is segmented into Infants (0 to 2 years) and Children (2 years & above). Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: Meningococcal Vaccine Market in LAMEA is expected to register a CAGR of 9.5% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Sanofi S.A., Walvax Biotechnology Co., Ltd., Bio-Manguinhos (Oswaldo Cruz Foundation), Bio-Med Pvt. Ltd., Chongqing Zhifei Biological Products Co., Ltd., Hualan Biological Engineering, Inc., Incepta Pharmaceuticals Ltd. and Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Scope of the Study
Market Segments Covered in the Report:
By Brand
- Bexsero
- Trumenba
- Nimenrix
- Menactra
- Menveo
- Other Brands
By Type
- Bivalent
- Quadrivalent
- Other Types
By Age Group
- Infants (0 to 2 years)
- Children (2 years & above)
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Sanofi S.A.
- Walvax Biotechnology Co., Ltd.
- Bio-Manguinhos (Oswaldo Cruz Foundation)
- Bio-Med Pvt. Ltd.
- Chongqing Zhifei Biological Products Co., Ltd.
- Hualan Biological Engineering, Inc.
- Incepta Pharmaceuticals Ltd.
- Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Meningococcal Vaccine Market, by Brand
1.4.2 LAMEA Meningococcal Vaccine Market, by Type
1.4.3 LAMEA Meningococcal Vaccine Market, by Age Group
1.4.4 LAMEA Meningococcal Vaccine Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Developments in Meningococcal Vaccine Market
Chapter 4. LAMEA Meningococcal Vaccine Market by Brand
4.1 LAMEA Bexsero Market by Country
4.2 LAMEA Trumenba Market by Country
4.3 LAMEA Nimenrix Market by Country
4.4 LAMEA Menactra Market by Country
4.5 LAMEA Menveo Market by Country
4.5.1.1 LAMEA Other Brands Market by Country
Chapter 5. LAMEA Meningococcal Vaccine Market by Type
5.1 LAMEA Bivalent Market by Country
5.2 LAMEA Quadrivalent Market by Country
5.3 LAMEA Other Types Market by Country
Chapter 6. LAMEA Meningococcal Vaccine Market by Age Group
6.1 LAMEA Children (2 years & above) and Adults Market by Country
6.2 LAMEA Infants(0 to 2 years) Market by Country
Chapter 7. LAMEA Meningococcal Vaccine Market by Country
7.1 Brazil Meningococcal Vaccine Market
7.1.1 Brazil Meningococcal Vaccine Market by Brand
7.1.2 Brazil Meningococcal Vaccine Market by Type
7.1.3 Brazil Meningococcal Vaccine Market by Age Group
7.2 Argentina Meningococcal Vaccine Market
7.2.1 Argentina Meningococcal Vaccine Market by Brand
7.2.2 Argentina Meningococcal Vaccine Market by Type
7.2.3 Argentina Meningococcal Vaccine Market by Age Group
7.3 UAE Meningococcal Vaccine Market
7.3.1 UAE Meningococcal Vaccine Market by Brand
7.3.2 UAE Meningococcal Vaccine Market by Type
7.3.3 UAE Meningococcal Vaccine Market by Age Group
7.4 Saudi Arabia Meningococcal Vaccine Market
7.4.1 Saudi Arabia Meningococcal Vaccine Market by Brand
7.4.2 Saudi Arabia Meningococcal Vaccine Market by Type
7.4.3 Saudi Arabia Meningococcal Vaccine Market by Age Group
7.5 South Africa Meningococcal Vaccine Market
7.5.1 South Africa Meningococcal Vaccine Market by Brand
7.5.2 South Africa Meningococcal Vaccine Market by Type
7.5.3 South Africa Meningococcal Vaccine Market by Age Group
7.6 Nigeria Meningococcal Vaccine Market
7.6.1 Nigeria Meningococcal Vaccine Market by Brand
7.6.2 Nigeria Meningococcal Vaccine Market by Type
7.6.3 Nigeria Meningococcal Vaccine Market by Age Group
7.7 Rest of LAMEA Meningococcal Vaccine Market
7.7.1 Rest of LAMEA Meningococcal Vaccine Market by Brand
7.7.2 Rest of LAMEA Meningococcal Vaccine Market by Type
7.7.3 Rest of LAMEA Meningococcal Vaccine Market by Age Group
Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
TABLE 1 LAMEA Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 2 LAMEA Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 3 LAMEA Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 4 LAMEA Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 5 LAMEA Bexsero Market by Country, 2016 - 2019, USD Million
TABLE 6 LAMEA Bexsero Market by Country, 2020 - 2026, USD Million
TABLE 7 LAMEA Trumenba Market by Country, 2016 - 2019, USD Million
TABLE 8 LAMEA Trumenba Market by Country, 2020 - 2026, USD Million
TABLE 9 LAMEA Nimenrix Market by Country, 2016 - 2019, USD Million
TABLE 10 LAMEA Nimenrix Market by Country, 2020 - 2026, USD Million
TABLE 11 LAMEA Menactra Market by Country, 2016 - 2019, USD Million
TABLE 12 LAMEA Menactra Market by Country, 2020 - 2026, USD Million
TABLE 13 LAMEA Menveo Market by Country, 2016 - 2019, USD Million
TABLE 14 LAMEA Menveo Market by Country, 2020 - 2026, USD Million
TABLE 15 LAMEA Other Brands Market by Country, 2016 - 2019, USD Million
TABLE 16 LAMEA Other Brands Market by Country, 2020 - 2026, USD Million
TABLE 17 LAMEA Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 18 LAMEA Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 19 LAMEA Bivalent Market by Country, 2016 - 2019, USD Million
TABLE 20 LAMEA Bivalent Market by Country, 2020 - 2026, USD Million
TABLE 21 LAMEA Quadrivalent Market by Country, 2016 - 2019, USD Million
TABLE 22 LAMEA Quadrivalent Market by Country, 2020 - 2026, USD Million
TABLE 23 LAMEA Other Types Market by Country, 2016 - 2019, USD Million
TABLE 24 LAMEA Other Types Market by Country, 2020 - 2026, USD Million
TABLE 25 LAMEA Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 26 LAMEA Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 27 LAMEA Children (2 years & above) and Adults Market by Country, 2016 - 2019, USD Million
TABLE 28 LAMEA Children (2 years & above) and Adults Market by Country, 2020 - 2026, USD Million
TABLE 29 LAMEA Infants(0 to 2 years) Market by Country, 2016 - 2019, USD Million
TABLE 30 LAMEA Infants(0 to 2 years) Market by Country, 2020 - 2026, USD Million
TABLE 31 LAMEA Meningococcal Vaccine Market by Country, 2016 - 2019, USD Million
TABLE 32 LAMEA Meningococcal Vaccine Market by Country, 2020 - 2026, USD Million
TABLE 33 Brazil Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 34 Brazil Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 35 Brazil Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 36 Brazil Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 37 Brazil Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 38 Brazil Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 39 Brazil Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 40 Brazil Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 41 Argentina Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 42 Argentina Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 43 Argentina Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 44 Argentina Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 45 Argentina Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 46 Argentina Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 47 Argentina Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 48 Argentina Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 49 UAE Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 50 UAE Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 51 UAE Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 52 UAE Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 53 UAE Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 54 UAE Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 55 UAE Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 56 UAE Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 57 Saudi Arabia Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 58 Saudi Arabia Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 59 Saudi Arabia Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 60 Saudi Arabia Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 61 Saudi Arabia Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 62 Saudi Arabia Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 63 Saudi Arabia Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 64 Saudi Arabia Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 65 South Africa Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 66 South Africa Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 67 South Africa Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 68 South Africa Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 69 South Africa Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 70 South Africa Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 71 South Africa Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 72 South Africa Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 73 Nigeria Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 74 Nigeria Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 75 Nigeria Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 76 Nigeria Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 77 Nigeria Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 78 Nigeria Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 79 Nigeria Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 80 Nigeria Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 81 Rest of LAMEA Meningococcal Vaccine Market, 2016 - 2019, USD Million
TABLE 82 Rest of LAMEA Meningococcal Vaccine Market, 2020 - 2026, USD Million
TABLE 83 Rest of LAMEA Meningococcal Vaccine Market by Brand, 2016 - 2019, USD Million
TABLE 84 Rest of LAMEA Meningococcal Vaccine Market by Brand, 2020 - 2026, USD Million
TABLE 85 Rest of LAMEA Meningococcal Vaccine Market by Type, 2016 - 2019, USD Million
TABLE 86 Rest of LAMEA Meningococcal Vaccine Market by Type, 2020 - 2026, USD Million
TABLE 87 Rest of LAMEA Meningococcal Vaccine Market by Age Group, 2016 - 2019, USD Million
TABLE 88 Rest of LAMEA Meningococcal Vaccine Market by Age Group, 2020 - 2026, USD Million
TABLE 89 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 90 Key Information – Pfizer, Inc.
TABLE 91 Key Information – Sanofi S.A.
TABLE 92 Key Information – Walvax Biotechnology Co., Ltd.
TABLE 93 Key Information – Bio-Manguinhos
TABLE 94 key information – Bio-Med Pvt. Ltd.
TABLE 95 key Information – Chongqing Zhifei Biological Products Co., Ltd.
TABLE 96 Key Information – Hualan Biological Engineering, Inc.
TABLE 97 key information – Incepta Pharmaceuticals Ltd.
TABLE 98 Key Information – Serum Institute of India Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research